Patent · US Active

Glycoprotein cancer biomarker

US8623611B2 · kind B2 · utility

13Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 11, 2010
Grant dateJan 7, 2014
Priority date—
Expiry dateJun 24, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2400/02
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention relates to glycoproteins having a cancer-specific glycoform. Cancer-specific glycoforms are useful in diagnostics and therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.